Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients.
作者信息
Takaya S, Bronsther O, Todo S, Abu-Elmagd K, Jain A, Alessiani M, Madariaga J, Marino I R, Selby R, Fung J J
机构信息
Department of Surgery, University of Pittsburgh Medical Center, Pennsylvania.
出版信息
Transplant Proc. 1991 Dec;23(6):3026-8.
Abstract
摘要
相似文献
1
Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients.肝脏再移植：接受FK506和环孢素治疗患者的比较。
Transplant Proc. 1991 Dec;23(6):3026-8.
2
FK 506 versus cyclosporine in pediatric liver transplantation.儿童肝移植中FK506与环孢素的比较
Transplant Proc. 1991 Dec;23(6):3010-5.
3
Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group.他克莫司与环孢素在肝移植中的长期比较。美国FK研究小组。
Transplant Proc. 1998 Jun;30(4):1399-400. doi: 10.1016/s0041-1345(98)00288-7.
4
Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine.在使用FK 506或环孢素进行免疫抑制的原位肝移植中的随机试验。
Transplant Proc. 1993 Feb;25(1 Pt 2):1130.
5
[Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation].[肝移植后免疫抑制治疗中他克莫司（FK 506）与环孢素的比较]
Z Gastroenterol. 1995 Oct;33(10):624-5.
6
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression.
Transplant Proc. 1998 Jun;30(4):1470-1. doi: 10.1016/s0041-1345(98)00320-0.
7
Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.接受环孢素A和他克莫司治疗的患者中慢性排斥反应的发生率及结果。
Transplant Proc. 1996 Dec;28(6):3183-4.
8
The spectrum of aspergillosis in liver transplant patients: comparison of FK 506 and cyclosporine immunosuppression.肝移植患者曲霉病的谱：FK 506与环孢素免疫抑制的比较
Transplant Proc. 1991 Dec;23(6):3040-1.
9
Liver retransplantation in adults: overall results and determinant factors affecting the outcome.成人肝脏再次移植：总体结果及影响预后的决定因素
Transplant Proc. 1991 Dec;23(6):3029-31.
10
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.一项关于在免疫抑制下使用FK 506与环孢素进行原位肝移植的随机试验。
Transplant Proc. 1991 Dec;23(6):2977-83.
引用本文的文献
1
The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation.原位肝移植术后胆道并发症的发生率、发生时间及处理
Ann Surg. 1994 Jan;219(1):40-5. doi: 10.1097/00000658-199401000-00007.
2
Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation.临床肝移植后应用前列腺素E1减少原发性无功能的发生
Transplant Proc. 1995 Apr;27(2):1862-7.
3
Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial.他克莫司：自身免疫性慢性活动性肝炎的一种潜在新疗法：一项开放标签初步试验的结果
Am J Gastroenterol. 1995 May;90(5):771-6.
4
Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.他克莫司。其药理学及在肝移植和肾移植中的治疗潜力综述。
Drugs. 1993 Oct;46(4):746-94. doi: 10.2165/00003495-199346040-00009.
本文引用的文献
1
Hepatic Retransplantation.肝脏再次移植
Transplant Proc. 1985 Feb;17(1):264-271.
2
Evolution of liver transplantation.肝移植的发展历程。
Hepatology. 1982 Sep-Oct;2(5):614-36. doi: 10.1002/hep.1840020516.
3
Augmentation of rat liver regeneration by FK 506 compared with cyclosporin.与环孢素相比，FK 506对大鼠肝脏再生的增强作用。
Lancet. 1989 Nov 25;2(8674):1248-9. doi: 10.1016/s0140-6736(89)91853-9.
4
Effect of cold ischemia time on the early outcome of human hepatic allografts preserved with UW solution.冷缺血时间对采用UW液保存的人肝移植早期结局的影响。
Transplantation. 1991 May;51(5):1000-4. doi: 10.1097/00007890-199105000-00013.
5
Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy.在环孢素或FK 506治疗下原发性人肝同种异体移植中的阳性交叉配型
Transplant Proc. 1991 Feb;23(1 Pt 1):396-9.
6
Protective effect of FK 506 against hepatic ischemia in rats.FK506对大鼠肝脏缺血的保护作用。
Transplant Proc. 1991 Feb;23(1 Pt 1):340-1.
Zotero 插件